Elizabeth Wood, PhD, is the founder & CEO of JURA Bio, Inc., a genomic medicines startup based in Boston, NYC, & Basel, Switzerland. JURA's mission is to develop next-generation therapies that improve patient outcomes across a number of indications. JURA has built the world's largest repository of AI-designed human antibodies and is pioneering probabilistic algorithms to learn from scaled data at the frontier of performance.